How
it works:
The
heart of the University of Minnesota bioartificial device is a hollow
fiber cartridge similar to that used for kidney dialysis. Freshly
harvested pig liver cells are suspended in a cold collagen solution
and injected inside the fibers. The cartridge is then connected
to the tubing circuit, and warm medium is perfused outside the fibers.
The collagen begins to gel once it is warmed, and within 24hrs.,
the liver cells pull on the collagen gel to contract to 60% of its
original diameter. In the resulting space, a nutrient-rich medium
stream is perfused for normal
functioning of the liver cells. At this point the device is ready
to be hooked up to a patient. The patient's blood is circulated
outside the hollow fibers. The fiber membranes allow toxins from
the blood to diffuse to the cells, but prevent immune molecules
from reaching the cells.

Two
hollow fiber cartridges, each containing approximately 40 g of cells,
are connected in series within an incubator maintained at 37° C. Because the patient's blood is taken
from a vein, it is oxygenated to maintain a sufficient amount of
oxygen for the hepatocytes. Temperature, pH and dissolved oxygen
are all monitored on-line. The rest of the system consists of the
necessary tubing and pumps.